The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Alere Inc

NYSE: ALR
Last

(U.S.) $53.57

Today's change-0.40 -0.75%
Updated July 6 1:39 PM EDT. Delayed by at least 15 minutes.
 

Alere Inc

NYSE: ALR
Last

(U.S.) $53.57

Today's change-0.40 -0.75%
Updated July 6 1:39 PM EDT. Delayed by at least 15 minutes.

Reversal following new 52-week high

Alere Inc is lower today, dropping (U.S.)$0.40 or 0.75% to (U.S.)$53.57 after setting a new 52-week high. Over the last five days, shares have gained 3.07% and are currently 1.86% off of the 52-week high. Shares have outperformed the S&P 500 by 31.90% during the last year.

Key company metrics

  • Open(U.S.) $53.70
  • Previous close(U.S.) $53.97
  • High(U.S.) $54.12
  • Low(U.S.) $53.51
  • Bid / Ask(U.S.) $53.55 / (U.S.) $53.57
  • YTD % change+40.97%
  • Volume626,731
  • Average volume (10-day)722,604
  • Average volume (1-month)496,966
  • Average volume (3-month)414,012
  • 52-week range(U.S.) $33.76 to (U.S.) $54.58
  • Beta1.90
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward22.08×
  • Forward PEG2.21×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$2.43
Updated July 6 1:39 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-7.65%

Although this company's net profit margin is negative, it is above the industry average and implies that Alere Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.53%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue608667649738
Total other revenue--------
Total revenue608667649738
Gross profit293313307340
Total cost of revenue315354342398
Total operating expense581633614747
Selling / general / administrative199222221298
Research & development28293334
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)39291717
Other operating expenses, total--------
Operating income273435-9
Interest income (expense), net non-operating-46-53-52-52
Gain (loss) on sale of assets--------
Other--------
Income before tax-20-22-25-58
Income after tax-12-35-91-52
Income tax, total-91365-7
Net income209111-98-50
Total adjustments to net income-5-5-5-5
Net income before extra. items-8-31-84-50
Minority interest0000
Equity in affiliates4462
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-13-36-89-55
Inc. avail. to common incl. extra. items204106-104-55
Diluted net income204106-104-55
Dilution adjustment--000
Diluted weighted average shares84848383
Diluted EPS excluding extraordinary itemsvalue per share-0.15-0.44-1.08-0.67
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.15-0.21-0.94-0.53